Its overexpression inhibited pancreatic cancer cell proliferation, migration, and invasion, via negatively regulating OTX1 [148], pointing toward miR-4516/OTX1 interaction as a novel therapeutic target for PC. Here, OTX1 is linked to pachyonychia congenita.